Trials / Completed
CompletedNCT05351580
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System - Advanced PD Data Collection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Great Lakes NeuroTechnologies Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To collect data to develop models that identify when patients with advanced Parkinson's disease (PD) are not responding well to their current therapy and may be ready to consider advanced therapy and when patients receiving advanced therapy are not responding well and need a therapy adjustment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DiSCERN | Smart watch Monitoring |
Timeline
- Start date
- 2022-07-21
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2022-04-28
- Last updated
- 2025-08-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05351580. Inclusion in this directory is not an endorsement.